Clinical Trial Update: Patello-Femoral Joint Post Market Clinical Follow-up Within the Knee Registry

View source ↗

Summary

A post-market clinical follow-up study in the patellofemoral joint within the knee registry has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis

Snippet

Sponsor: Zimmer Biomet | Conditions: Arthritis | Status: WITHDRAWN